Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

There are several potential events that could occur which could change the financial landscape at any time. If the F.D.A. grants O.D.D. for MANF for Retinitis Pigmentosa which I expect will happen it could be the catalyst for a major move higher as an initial O.D.D. for MANF for additional orphan diseases would be expected. If the company is able to ink a development partnership for MANF for R.P. with a reasonable up-front cash payment in the $10M range then an initial share price in the .25+ range is quite possible.

Follow this scenario with "firm" revenue numbers for LymPro in the $25M+ range for 2015 and several times that amount for 2016 and the share price firms up in the .50 range as additional O.D.D. applications for MANF are filed and additional development partnerships anticipated.

A reasonable share price would be .50 by the end of 2Q2015 although it could be much higher. Who thought the share price of JAZZ would explode like it did?

Considering the recent price action I don't see much if any downside buying at the current share price.

I don't know of another stock currently under a dime that has the potential that AMBS offers.

Interesting weeks ahead.

Twitter: @AmarantusBio .... 10,200 followers.